4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001671311-25-000005
Chief Operating Officer sold 50,291 shares at $18.97 ($954,066)
- Chief Operating Officer acquired 50,291 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jarrett Jennifer · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +50,291 | $1.23 | $61,737 | 264,523 | D |
| 2025-11-07 | Sale : show line 2 in the form 10b5-1 | −50,291 | $18.97 | $954,066 | 214,232 | D |
| Open-market sales · 50,291 sh · avg $18.97 · $954,066 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-07 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −50,291 | $1.23 | $61,737 | 80,583 | D |
Loading xslF345X05/wk-form4_1762981456.xml…